The rising prevalence of obesity around the globe places an increasing burden on the health of populations, on healthcare systems and on overall economies. A major challenge for researchers is to quantify the effect of these ...
Aug 26, 2011
3
0
A significant challenge in addressing the country's opioid crisis is that policies based on past patterns of behavior may have unintended consequences because those patterns change over time. Collaborating with the U.S. Food ...
Jun 24, 2022
1
103
Banning menthol flavors in cigarettes could reduce smoking by 15% by having smokers giving up tobacco products altogether or switching to e-cigarettes and other nicotine vaping products—avoiding 16,250 tobacco-related deaths ...
Sep 3, 2021
0
43
Patients kept asking a question that Nathan Lo, MD, Ph.D., infectious disease specialist, had a hard time answering: How often should I get my booster shot for COVID-19?
Mar 6, 2024
1
33
Alzheimer's disease (AD) is a progressive neurodegenerative disorder affecting tens of millions of people worldwide, and it is the most common cause of dementia. Early-onset AD is typically associated with mutations in the ...
May 12, 2023
0
56
The mean length of the preclinical detectable phase (PCDP) of open-angle glaucoma is estimated to be over 10 years, according to a study published online Nov. 23 in JAMA Ophthalmology.
Nov 29, 2022
0
2
Scientists have successfully constructed a three-dimensional human epidermis based on predictions made by their mathematical model of epidermal homeostasis, providing a new tool for basic research and drug development.
Jan 25, 2019
0
70
Two newer classes of drugs to treat adult-onset diabetes may be no more effective than the old standby, yet they cost significantly more over the course of a patient's disease.
Feb 28, 2014
0
5
Replacing visual acuity screenings for new Medicare enrollees with coverage of a dilated eye exam for healthy patients entering the government insurance program for the elderly "would be highly cost-effective," suggests a ...
Jan 9, 2012
0
0
A person with type 2 diabetes may spend an average of nearly $85,500 to treat the disease and its complications over his or her lifetime, reports a new study in the American Journal of Preventive Medicine. The earlier diabetes ...
Aug 9, 2013
0
0
